| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $130.7M | +6.0% |
| Cost of Revenue | $75.3M | +13.5% |
| Gross Profit | $55.4M | -2.7% |
| R&D Expense | $8.5M | +12.2% |
| SG&A Expense | $26.1M | +22.5% |
| Operating Income | $3.4M | -67.5% |
| Pre-tax Income | $3.5M | -68.7% |
| Income Tax | $563K | -67.0% |
| Net Income | $2.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.8M | -56.2% |
| Accounts Receivable | $29.5M | +62.3% |
| Inventory | $26.8M | +33.6% |
| Current Assets | $78.8M | -8.1% |
| Total Assets | $152.3M | +12.9% |
| Current Liabilities | $31.9M | +31.5% |
| Long-term Debt | $7.9M | -34.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.8M | -76.4% |
| Capital Expenditures | $1.3M | +2.6% |
| Investing Cash Flow | -$20.1M | -1453.1% |
| Financing Cash Flow | -$8.6M | -155.4% |
| Free Cash Flow | $2.5M | -83.3% |
| -69.1% |
| EPS (Basic) | $0.24 | -70.7% |
| EPS (Diluted) | $0.24 | -69.6% |
| Total Liabilities |
| $52.5M |
| +36.2% |
| Stockholders' Equity | $99.8M | +3.6% |